Dudediligence.

Aura Biosciences, Inc

AURANASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$876,248

10 notices · 164,747 sh

Nov 2025 to Oct 2026

Reported ·

$40.1M

14 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 14 reported sales carry the 10b5-1 box. Together they are 6.86% of the shares on issue.

PLANNED · FORM 144Nov 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-06-16: Gibney Anthony, Form 1442026-04-16: Kilroy Conor, Form 1442026-02-17: Kilroy Conor, Form 1442026-02-17: Plavsic Mark, Form 1442026-02-17: Hopkins Janet Jill, Form 1442026-02-17: Elazzouzi Amy, Form 1442026-02-17: de los Pinos Elisabet, Form 1442026-01-20: Elazzouzi Amy, Form 1442026-01-20: de los Pinos Elisabet, Form 1442025-11-17: Hopkins Janet Jill, Form 1442025-10-16: Plavsic Mark, sold2025-10-29: de los Pinos Elisabet, sold2025-10-29: Elazzouzi Amy, sold2025-11-17: Hopkins Janet Jill, sold2026-01-20: de los Pinos Elisabet, sold2026-01-20: Elazzouzi Amy, sold2026-02-17: de los Pinos Elisabet, sold2026-02-17: Elazzouzi Amy, sold2026-02-17: Hopkins Janet Jill, sold2026-02-17: Plavsic Mark, sold2026-02-17: Kilroy Conor, sold2026-04-16: Kilroy Conor, sold2026-05-07: Matrix Capital Management Company, LP, sold2026-06-16: Gibney Anthony S, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-06-16Gibney Anthony, See Remarks$82,330
12,824 shno plan date144 ↗
Form 4, 2026-06-16: sold 12,824 at $6.42 Form 4 ↗
2026-04-16Kilroy Conor, See Remarks$82,402
11,738 shno plan date144 ↗
Form 4, 2026-04-16: sold 11,738 at $7.02 Form 4 ↗
2026-02-17Kilroy Conor, See Remarks$61,037
12,079 shno plan date144 ↗
Form 4, 2026-02-17: sold 12,079 at $5.05 Form 4 ↗
2026-02-17Plavsic Mark, Chief Technology Officer$80,271
15,890 shno plan date144 ↗
Form 4, 2026-02-17: sold 15,890 at $5.05 Form 4 ↗
2026-02-17Hopkins Janet Jill, Chief Medical Officer$103,231
20,401 shno plan date144 ↗
Form 4, 2026-02-17: sold 20,401 at $5.06 Form 4 ↗
2026-02-17Elazzouzi Amy, Senior Vice President, Finance$43,261
8,549 shno plan date144 ↗
Form 4, 2026-02-17: sold 8,549 at $5.06 Form 4 ↗
2026-02-17de los Pinos Elisabet, See Remarks$241,063
47,648 shno plan date144 ↗
Form 4, 2026-02-17: sold 47,648 at $5.06 Form 4 ↗
2026-01-20Elazzouzi Amy, Senior Vice President, Finance$7,684
1,581 shno plan date144 ↗
Form 4, 2026-01-20: sold 1,581 at $4.86 Form 4 ↗
2026-01-20de los Pinos Elisabet, See Remarks$82,234
16,928 shno plan date144 ↗
Form 4, 2026-01-20: sold 16,928 at $4.86 Form 4 ↗
2025-11-17Hopkins Janet Jill, Chief Medical Officer$92,735
17,109 shno plan date144 ↗
Form 4, 2025-11-17: sold 17,109 at $5.42 Form 4 ↗